Evaluation of a Novel Lip Bumper With Integrated Distal Shoe Appliance in Preventing Second Molar Impaction in Children With Anterior Deep Bite (Novel Lip Bump)

August 18, 2025 updated by: Sally Abd-ElMeniem ElHaddad, Dar Al Uloom University

The goal of this clinical trial is to evaluate the effectiveness of a novel lip bumper with an integrated distal shoe in preventing second molar impaction in children aged 8-10 years with anterior open bite during the mixed dentition stage.

The main questions it aims to answer are:

  • Does the integrated distal shoe significantly reduce the risk of second molar impaction compared to conventional lip bumpers?
  • Does the appliance improve anterior open bite correction and influence lower incisor inclination?

Researchers will compare Group I (lip bumper with distal shoe) to Group II (conventional lip bumper) to see if the modified appliance prevents mesial drift of first molars and improves eruption outcomes of second molars.

Participants will:

  • Undergo initial records including panoramic and cephalometric radiographs, study models, and intraoral photos
  • Be fitted with one of the two appliances and followed up every 6 weeks over a 12-month period
  • Receive radiographic and clinical evaluation of second molar eruption
  • Complete assessments related to overbite changes, incisor inclination, comfort, and compliance This trial seeks to inform early orthodontic protocols and may offer a dual-function solution for both molar guidance and open bite correction.

Study Overview

Detailed Description

This clinical research study is focused on improving early orthodontic care for children who have an anterior deep bite-a condition where the upper teeth excessively overlap the lower front teeth-and are at risk of second molar impaction, a complication where the posterior teeth do not emerge properly. Left untreated, these issues can lead to long-term dental problems including poor bite alignment, crowding, or the need for surgical intervention.

Orthodontists often use a device called a lip bumper to reduce pressure from the lips on the lower front teeth, making room for crowded teeth and promoting healthy jaw development. However, a well-known downside of using a lip bumper-especially in young children-is that it can cause the first molars to drift forward. This forward movement can block the path for the second molars, increasing the risk that they will not erupt normally.

This study introduces a novel orthodontic appliance that aims to solve both problems at once. The new device combines the benefits of a traditional lip bumper with a "distal shoe"-a small guiding component that helps maintain proper space for the second molars to erupt. By doing so, it seeks not only to correct deep bite problems but also to prevent the common and serious issue of molar impaction.

The study will involve children between the ages of 8 and 10, a key stage of dental development. Participants will receive either the new dual-purpose device or a standard lip bumper and will be monitored over the course of a year. Throughout this period, researchers will examine how the teeth are moving, whether the posterior molars are erupting properly, and how well the deep bite is improving.

In addition to clinical evaluations, the study will gather feedback from children and their parents about comfort, ease of use, and any issues related to the appliance. Understanding patient experience is a vital part of assessing whether this new approach can be widely recommended in pediatric dental care.

Ultimately, this research aims to offer a more comprehensive and preventive solution for young patients undergoing early orthodontic treatment. If the new appliance proves effective, it could significantly reduce the need for more complex procedures later in life and promote better long-term dental health.

Ethical safeguards, including informed consent from parents and assent from participating children, are in place to ensure safety and understanding. The study has received institutional ethics approval and will be conducted under regular clinical monitoring.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age between 8 and 11 years
  • In mixed dentition stage (presence of permanent first molars and incisors; unerupted second molars)
  • Presence of an anterior deep bite of ≥ 2 mm (measured vertically between upper and lower incisors)
  • Class I or mild Class II malocclusion
  • Good general health with no systemic conditions that may affect dental development or treatment
  • Written informed consent obtained from the parent or legal guardian and assent from the child

Exclusion Criteria:

  • History of previous orthodontic treatment
  • Presence of craniofacial anomalies (e.g., cleft lip/palate) or syndromic conditions
  • Diagnosis of systemic diseases that affect bone metabolism or craniofacial growth (e.g., juvenile rheumatoid arthritis, osteogenesis imperfecta)
  • Evidence of poor oral hygiene or active caries requiring urgent dental care
  • Use of any medication known to affect dental development (e.g., long-term corticosteroids, antiepileptics)
  • Behavioral or developmental disorders that would preclude cooperation with appliance wear or study procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Lip Bumper with Integrated Distal Shoe
Participants in this group will receive a novel orthodontic appliance that combines a traditional lip bumper with an integrated distal shoe. The appliance is designed to prevent mesial migration of the first molars and guide proper eruption of the second permanent molars. It also functions to relieve anterior deep bite by reducing lip pressure and promoting vertical and sagittal arch development. The appliance will be worn continuously for a period of 12 months with follow-up visits every 6 weeks for adjustments and monitoring.
This novel appliance integrates a traditional lip bumper with a distal shoe extension designed to engage the mesial surface of the unerupted second permanent molar. The goal is to prevent mesial movement of the first molars and guide proper eruption of the second molars while simultaneously addressing anterior deep bite by eliminating lip pressure and promoting vertical incisor development. The device will be custom-fabricated for each participant and will be worn for 12 months, with clinical and radiographic evaluations conducted every 6 weeks.
Active Comparator: Conventional Lip Bumper
Participants in this group will receive a standard lip bumper appliance, commonly used in interceptive orthodontics to relieve lower arch crowding and eliminate lip pressure. This appliance does not include any mechanism to prevent mesial drift of the first molars or guide the eruption path of second molars. It will be used in the same time frame and follow-up schedule as the experimental group to allow direct comparison of outcomes.
The conventional lip bumper is an interceptive orthodontic appliance used to alleviate lower anterior crowding, eliminate perioral muscle pressure, and promote dental arch expansion. It does not include a distal shoe component and therefore offers no guidance for second molar eruption. This device will also be custom-fabricated and worn for 12 months, with scheduled monitoring every 6 weeks to assess treatment progress and compare outcomes with the experimental device.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiographic Assessment of Second Molar Eruption Angle and Position
Time Frame: At baseline and after 12 months of appliance use

Radiographic Eruption Angle Measurement Scale (in degrees)

Objectives:

To evaluate the effect of the appliance on the eruption trajectory and final position of the second permanent molars, using radiographic measurements to detect impaction or favorable eruption patterns.

  • Measurement Method: Panoramic radiograph using digital angle analysis tools to measure the angle between the long axis of the second molar and a stable reference line (e.g., occlusal plane or mandibular base).
  • Scale Range:

    • Minimum value: 0° (perfect vertical eruption)
    • Maximum value: ~90° (severely impacted or horizontal position)
  • Interpretation:

    • Lower scores (closer to 0°) indicate a more favorable eruption position and vertical alignment.
    • Higher scores (closer to 90°) indicate a worse outcome, suggesting impaction or abnormal angulation.

Angular and positional changes of the mandibular second permanent molars (in degrees or millimeters) as observed on standardized panoramic radiographs

At baseline and after 12 months of appliance use

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Overbite (in mm)
Time Frame: Baseline and 12 months

Measurement Method: Measured on study models from the incisal edge of the maxillary central incisor to the incisal edge of the opposing mandibular incisor at the point of greatest overlap, when posterior teeth are in occlusion.

Scale Range:

Minimum value: 0 mm (edge-to-edge or open bite)

Maximum value: Typically up to 6-8 mm (deep bite), depending on the patient's anatomy

Interpretation:

Lower scores after treatment indicate improvement (reduced deep bite), representing a better clinical outcome Higher scores after treatment suggest persistence or worsening of the deep bite, representing a worse clinical outcome

Baseline and 12 months
Lower Incisor Inclination (IMPA - Incisor Mandibular Plane Angle) in degrees
Time Frame: Baseline and 12 months

Measurement Method:

IMPA is measured on standardized lateral cephalometric radiographs as the angle between the long axis of the most prominent mandibular central incisor and the mandibular plane (typically drawn from gonion to menton).

Scale Range:

Minimum value: ~80° (retroclined lower incisors) Maximum value: ~110° (proclined lower incisors) (Typical normal range: 90° ± 5°)

Interpretation:

Lower scores (e.g., < 85°) indicate retroclination of the lower incisors Higher scores (e.g., > 95°) indicate proclination

Baseline and 12 months
Visual Analog Scale for Orthodontic Comfort and Tolerance (0-10 scale) Patient-Reported Comfort and Appliance Tolerance
Time Frame: 1 week, 6 weeks, 3 months, and 12 months

Patients will complete a self-reported questionnaire at specified intervals (1 week, 6 weeks, 3 months, and 12 months) rating their comfort and tolerance of the appliance. The scale used is a Visual Analog Scale (VAS) ranging from 0 to 10.

Scale Range:

Maximum value: 10 = No comfort at all / appliance is very uncomfortable and intolerable Minimum value: 0 = Very comfortable / appliance is completely tolerable

Interpretation:

Lower scores indicate better outcomes, reflecting greater comfort and tolerance to the appliance

Higher scores suggest discomfort, poor adaptation, or potential complications impacting patient compliance

1 week, 6 weeks, 3 months, and 12 months
Orthodontic Appliance Compliance Assessment Scale (0-5 scale)
Time Frame: at each follow-up visit (every 6 weeks)

Orthodontist will assess patient compliance based on appliance wear, cleanliness, and adherence to instructions. Scoring will be based on clinical observation and patient self-report, using a standardized 6-point scale.

Scale Range:

0: Non-compliant - never wears appliance or refuses treatment

  1. Very poor compliance - wears appliance <25% of the time
  2. Poor compliance - inconsistent use, visible neglect of hygiene
  3. Moderate compliance - wears appliance ~50-75% of expected time
  4. Good compliance - minor lapses in wear or cleaning
  5. Excellent compliance - wears appliance as instructed, maintains hygiene

Interpretation:

Higher scores (4-5) reflect better outcomes, indicating strong adherence to treatment and greater likelihood of therapeutic success

Lower scores (0-2) indicate poor cooperation, which may reduce treatment effectiveness

at each follow-up visit (every 6 weeks)
Soft Tissue Reaction Severity Scale (0-3 score per site)
Time Frame: At each 6-week follow-up visit

Clinical examination will be performed to assess the soft tissues adjacent to the appliance. Adverse reactions such as ulceration, erythema, swelling, and hyperplasia will be documented using a standardized 4-point severity scale.

Scale Range:

0: No reaction - healthy tissue

  1. Mild - slight redness or irritation, no ulceration
  2. Moderate - noticeable inflammation, small ulcers or discomfort
  3. Severe - pronounced ulceration, swelling, or tissue overgrowth requiring intervention

Interpretation:

Lower scores (0-1) indicate better outcomes, reflecting good appliance biocompatibility and patient adaptation Higher scores (2-3) indicate worse outcomes, signifying poor tissue response or intolerance to the appliance

At each 6-week follow-up visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 15, 2025

Primary Completion (Estimated)

July 15, 2026

Study Completion (Estimated)

November 1, 2026

Study Registration Dates

First Submitted

May 30, 2025

First Submitted That Met QC Criteria

June 8, 2025

First Posted (Actual)

June 11, 2025

Study Record Updates

Last Update Posted (Actual)

August 22, 2025

Last Update Submitted That Met QC Criteria

August 18, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 33-06-2025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The following de-identified individual participant data (IPD) will be shared:

Demographic data: age, sex, and baseline dental classification (e.g., type of malocclusion)

Radiographic measurements: second molar eruption angle and position at baseline and 12 months

Cephalometric data: baseline and post-treatment incisor mandibular plane angle (IMPA)

Overbite measurements: baseline and post-treatment vertical overlap (in mm)

Patient-reported outcomes: responses from comfort and compliance questionnaires

Adverse event reports: type, frequency, and severity of any soft tissue complications

Compliance assessments: clinician-rated appliance wear and follow-up adherence

All shared data will be fully anonymized in accordance with ethical standards and privacy regulations.

IPD Sharing Time Frame

IPD Availability Timeline

Start Date for IPD Availability:

Six months after publication of the primary study results in a peer-reviewed journal.

End Date for IPD Availability:

Five years from the start date of data sharing.

During this period, de-identified individual participant data and related supporting documents (such as the study protocol and statistical analysis plan) will be made available to qualified researchers upon reasonable request and subject to data use agreements.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bite

Subscribe